ArticleBMC plant biology2025
Multi-omics and field experiments reveal the mechanism of Pseudomonas palleroniana P6 promoting the growth and polyphyllins accumulation in Paris polyphylla.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multi-Omics Integration Reveals Temporal Partitioning Between Metabolic Priming and Proliferative Expansion in PGPR-Treated Cherry Plants.International journal of molecular sciences · 2026Article
- The effect of chili pepper-Chinese chives intercropping on rhizosphere microorganisms and root-stem endophytes.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundParis polyphylla (P. polyphylla), a medicinal herb valued in traditional Chinese medicine, struggles with slow growth rate and long maturation periods, hindering sustainable cultivation and commercial production-especially for polyphyllins, its key bioactive compounds. Although plant growth-promoting rhizobacteria (PGPR) have shown potential in enhancing crop productivity and secondary metabolite accumulation, their application in slow-growing medicinal plants like P. polyphylla remains underexplored.
resultsIn this study, 25 strains with inorganic phosphorus-dissolving, potassium-solubilizing and nitrogen-fixing abilities were isolated from the rhizosphere soil of P. polyphylla, mainly belonging to Bacillus, Pseudomonas, and Rhizobium. Among them, the strain Pseudomonas palleroniana P6 exhibited the best growth-promoting effect on grass. The whole genome analysis demonstrated that P. palleroniana P6 could promote forage growth by secreting phosphatases, organic acids, and producing substances like IAA and siderophore. Field experiments were carried out to further validate the impact of P. palleroniana P6 on the growth of P. polyphylla. The results revealed that P. palleroniana P6 remarkably enhanced the biomass of P. polyphylla root and the content of polyphyllin I, II, and VII, and significantly increased the soil available potassium content. The transcriptome results indicated that the application of P. palleroniana P6 considerably increased the expression of genes related to the plant hormone signal transduction pathway involved in growth regulation, cholesterol synthesis, terpenoid backbone synthesis and the energy metabolism pathway associated with polyphyllins synthesis in P. polyphylla.
conclusionsThis study systematically investigated the growth-promoting effects and secondary metabolic regulation mechanisms of the bacterial inoculant P. palleroniana P6 on the endangered medicinal plant P. polyphylla. The findings highlight the potential of P. palleroniana P6 in promoting plant growth and enhancing polyphenol accumulation in P. polyphylla, providing valuable insights for the application of microbial inoculants in enhancing the growth and bioactive compound production of perennial medicinal plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.